Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
|Articles|July 7, 2011
Pedunculated Submucosal Uterine Fibroid
Author(s)OBGYN.net Staff
The following images are of a 42 y/o woman with a chief complaint of DUB. She is not on hormones, due to mitigating factors.
Advertisement
The following images are of a 42 y/o woman with a chief complaint of DUB. She is not on hormones, due to mitigating factors.
It is my belief that this is a uterine fibroid. The patient has been scheduled for a sonohysterogram, and possibly a uterine artery embolization if warranted. If either of the procedures are performed, I will post additional images.
Email:
Advertisement
Related to this article
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes
3
Perimenopause and mental health: Beyond hormonal vs psychological
4
Real-world data link fezolinetant to fewer nighttime awakenings
5